The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Double blind multicenter phase III GORTEC trial evaluating the efficacy of oral immune modulating formulae therapy during adjuvant radiochemotherapy in head and neck squamous cell carcinoma (HNSCC).
 
Pierre Boisselier
Honoraria - Merck Serono
 
Pierre Graff-Cailleaud
No Relationships to Disclose
 
Christian Sire
No Relationships to Disclose
 
Olivier Gallocher
No Relationships to Disclose
 
Sandrine Lavau-Denes
No Relationships to Disclose
 
Muriel Garcia-Ramirez
No Relationships to Disclose
 
Marc Alfonsi
No Relationships to Disclose
 
Didier Cupissol
No Relationships to Disclose
 
Marie-Christine Kaminsky
No Relationships to Disclose
 
Stephanie Fiore
No Relationships to Disclose
 
Nicolas Flori
Employment - Baxter; Fresenius Kabi
Leadership - Fresenius Kabi
Honoraria - Fresenius Kabi
Consulting or Advisory Role - Fresenius Kabi
Speakers' Bureau - Fresenius Kabi
Expert Testimony - Fresenius Kabi
 
Helene de Forges
No Relationships to Disclose
 
Renaud Garrel
No Relationships to Disclose
 
Chloe Janiszewski
Travel, Accommodations, Expenses - Orkyn
 
Simon Thezenas
No Relationships to Disclose
 
Pierre Senesse
Honoraria - Baxter; Boehringer Ingelheim; Fresenius Kabi; Ipsen; Lactalis; Nutricia
Consulting or Advisory Role - Aguettant; Baxter; Fresenius Kabi; Nestle health science
Research Funding - Ipsen (Inst); Nestle health science (Inst)
Travel, Accommodations, Expenses - Aguettant; AVEO; Baxter; Fresenius Kabi